Microdevices for Non-Invasive Detection of Bladder Cancer

Bladder cancer holds the record for the highest lifetime cost on a per-patient basis. This is due to high recurrence rates, which necessitate invasive and costly long-term evaluation methods such as cystoscopy and imaging. Microfluidics is emerging as an important approach to contribute to initial d...

Full description

Bibliographic Details
Main Authors: Constantine Tzouanas, Joey Sze Yun Lim, Ya Wen, Jean Paul Thiery, Bee Luan Khoo
Format: Article
Language:English
Published: MDPI AG 2017-11-01
Series:Chemosensors
Subjects:
Online Access:https://www.mdpi.com/2227-9040/5/4/30
_version_ 1818912767782944768
author Constantine Tzouanas
Joey Sze Yun Lim
Ya Wen
Jean Paul Thiery
Bee Luan Khoo
author_facet Constantine Tzouanas
Joey Sze Yun Lim
Ya Wen
Jean Paul Thiery
Bee Luan Khoo
author_sort Constantine Tzouanas
collection DOAJ
description Bladder cancer holds the record for the highest lifetime cost on a per-patient basis. This is due to high recurrence rates, which necessitate invasive and costly long-term evaluation methods such as cystoscopy and imaging. Microfluidics is emerging as an important approach to contribute to initial diagnosis and follow-up, by enabling the precise manipulation of biological samples. Specifically, microdevices have been used for the isolation of cells or genetic material from blood samples, sparking significant interest as a versatile platform for non-invasive bladder cancer detection with voided urine. In this review, we revisit the methods of bladder cancer detection and describe various types of markers currently used for evaluation. We detail cutting-edge technologies and evaluate their merits in the detection, screening, and diagnosis of bladder cancer. Advantages of microscale devices over standard methods of detection, as well as their limitations, are provided. We conclude with a discussion of criteria for guiding microdevice development that could deepen our understanding of prognoses at the level of individual patients and the underlying biology of bladder cancer development. Collectively, the development and widespread application of improved microfluidic devices for bladder cancer could drive treatment breakthroughs and establish widespread, tangible outcomes on patients’ long-term survival.
first_indexed 2024-12-19T23:19:50Z
format Article
id doaj.art-f2aa67f3c3764f1094b992b8a267d24b
institution Directory Open Access Journal
issn 2227-9040
language English
last_indexed 2024-12-19T23:19:50Z
publishDate 2017-11-01
publisher MDPI AG
record_format Article
series Chemosensors
spelling doaj.art-f2aa67f3c3764f1094b992b8a267d24b2022-12-21T20:02:00ZengMDPI AGChemosensors2227-90402017-11-01543010.3390/chemosensors5040030chemosensors5040030Microdevices for Non-Invasive Detection of Bladder CancerConstantine Tzouanas0Joey Sze Yun Lim1Ya Wen2Jean Paul Thiery3Bee Luan Khoo4Department of Bioengineering, Rice University, Houston, TX 77005, USABioSystems and Micromechanics (BioSyM) IRG, Singapore-MIT Alliance for Research and Technology (SMART) Centre, Singapore 138602, SingaporePlug and Play Tech Center, Sunnyvale, CA 94043, USADepartment of Biochemistry Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, SingaporeBioSystems and Micromechanics (BioSyM) IRG, Singapore-MIT Alliance for Research and Technology (SMART) Centre, Singapore 138602, SingaporeBladder cancer holds the record for the highest lifetime cost on a per-patient basis. This is due to high recurrence rates, which necessitate invasive and costly long-term evaluation methods such as cystoscopy and imaging. Microfluidics is emerging as an important approach to contribute to initial diagnosis and follow-up, by enabling the precise manipulation of biological samples. Specifically, microdevices have been used for the isolation of cells or genetic material from blood samples, sparking significant interest as a versatile platform for non-invasive bladder cancer detection with voided urine. In this review, we revisit the methods of bladder cancer detection and describe various types of markers currently used for evaluation. We detail cutting-edge technologies and evaluate their merits in the detection, screening, and diagnosis of bladder cancer. Advantages of microscale devices over standard methods of detection, as well as their limitations, are provided. We conclude with a discussion of criteria for guiding microdevice development that could deepen our understanding of prognoses at the level of individual patients and the underlying biology of bladder cancer development. Collectively, the development and widespread application of improved microfluidic devices for bladder cancer could drive treatment breakthroughs and establish widespread, tangible outcomes on patients’ long-term survival.https://www.mdpi.com/2227-9040/5/4/30microdevicesnon-invasive proceduresbladder cancerurine
spellingShingle Constantine Tzouanas
Joey Sze Yun Lim
Ya Wen
Jean Paul Thiery
Bee Luan Khoo
Microdevices for Non-Invasive Detection of Bladder Cancer
Chemosensors
microdevices
non-invasive procedures
bladder cancer
urine
title Microdevices for Non-Invasive Detection of Bladder Cancer
title_full Microdevices for Non-Invasive Detection of Bladder Cancer
title_fullStr Microdevices for Non-Invasive Detection of Bladder Cancer
title_full_unstemmed Microdevices for Non-Invasive Detection of Bladder Cancer
title_short Microdevices for Non-Invasive Detection of Bladder Cancer
title_sort microdevices for non invasive detection of bladder cancer
topic microdevices
non-invasive procedures
bladder cancer
urine
url https://www.mdpi.com/2227-9040/5/4/30
work_keys_str_mv AT constantinetzouanas microdevicesfornoninvasivedetectionofbladdercancer
AT joeyszeyunlim microdevicesfornoninvasivedetectionofbladdercancer
AT yawen microdevicesfornoninvasivedetectionofbladdercancer
AT jeanpaulthiery microdevicesfornoninvasivedetectionofbladdercancer
AT beeluankhoo microdevicesfornoninvasivedetectionofbladdercancer